Guyot AC - Search Results

1

Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency.

Broca-Brisson L, Harati R, Disdier C, Mozner O, Gaston-Breton R, Maïza A, Costa N, Guyot AC, Sarkadi B, Apati A, Skelton MR, Madrange L, Yates F, Armengaud J, Hamoudi R, Mabondzo A. Broca-Brisson L, et al. Among authors: guyot ac. Elife. 2023 Oct 13;12:RP88459. doi: 10.7554/eLife.88459. Elife. 2023. PMID: 37830910 Free PMC article.

2

Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency.

Mabondzo A, Harati R, Broca-Brisson L, Guyot AC, Costa N, Cacciante F, Putignano E, Baroncelli L, Skelton MR, Saab C, Martini E, Benech H, Joudinaud T, Gaillard JC, Armengaud J, Hamoudi R. Mabondzo A, et al. Among authors: guyot ac. Front Mol Neurosci. 2023 Mar 24;16:1118707. doi: 10.3389/fnmol.2023.1118707. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37063368 Free PMC article.

3

Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.

Pavoni S, Jarray R, Nassor F, Guyot AC, Cottin S, Rontard J, Mikol J, Mabondzo A, Deslys JP, Yates F. Pavoni S, et al. Among authors: guyot ac. PLoS One. 2018 Dec 17;13(12):e0209150. doi: 10.1371/journal.pone.0209150. eCollection 2018. PLoS One. 2018. PMID: 30557391 Free PMC article.

4

Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model.

Roux GL, Jarray R, Guyot AC, Pavoni S, Costa N, Théodoro F, Nassor F, Pruvost A, Tournier N, Kiyan Y, Langer O, Yates F, Deslys JP, Mabondzo A. Roux GL, et al. Among authors: guyot ac. Sci Rep. 2019 Nov 5;9(1):16310. doi: 10.1038/s41598-019-52213-6. Sci Rep. 2019. PMID: 31690750 Free PMC article.

5

A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment.

Guyot AC, Leuxe C, Disdier C, Oumata N, Costa N, Roux GL, Varela PF, Duchon A, Charbonnier JB, Herault Y, Pavoni S, Galons H, Andriambeloson E, Wagner S, Meijer L, Lund AK, Mabondzo A. Guyot AC, et al. Sci Rep. 2020 Jan 24;10(1):1143. doi: 10.1038/s41598-020-57560-3. Sci Rep. 2020. PMID: 31980673 Free PMC article.

6

Author Correction: A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment.

Guyot AC, Leuxe C, Disdier C, Oumata N, Costa N, Le Roux G, Varela PF, Duchon A, Charbonnier JB, Herault Y, Pavoni S, Galons H, Andriambeloson E, Wagner S, Meijer L, Lund AK, Mabondzo A. Guyot AC, et al. Sci Rep. 2020 Jul 3;10(1):10983. doi: 10.1038/s41598-020-67127-x. Sci Rep. 2020. PMID: 32620926 Free PMC article.

7

Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.

Bousquet L, Pruvost A, Guyot AC, Farinotti R, Mabondzo A. Bousquet L, et al. Among authors: guyot ac. Antimicrob Agents Chemother. 2009 Mar;53(3):896-902. doi: 10.1128/AAC.00733-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075072 Free PMC article.

8

Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration.

Mabondzo A, Bottlaender M, Guyot AC, Tsaouin K, Deverre JR, Balimane PV. Mabondzo A, et al. Among authors: guyot ac. Mol Pharm. 2010 Oct 4;7(5):1805-15. doi: 10.1021/mp1002366. Epub 2010 Sep 15. Mol Pharm. 2010. PMID: 20795735

9

Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice.

Oppenheim HA, Lucero J, Guyot AC, Herbert LM, McDonald JD, Mabondzo A, Lund AK. Oppenheim HA, et al. Among authors: guyot ac. Part Fibre Toxicol. 2013 Dec 17;10:62. doi: 10.1186/1743-8977-10-62. Part Fibre Toxicol. 2013. PMID: 24344990 Free PMC article.

10

In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.

Lacombe O, Videau O, Chevillon D, Guyot AC, Contreras C, Blondel S, Nicolas L, Ghettas A, Bénech H, Thevenot E, Pruvost A, Bolze S, Krzaczkowski L, Prévost C, Mabondzo A. Lacombe O, et al. Among authors: guyot ac. Mol Pharm. 2011 Jun 6;8(3):651-63. doi: 10.1021/mp1004614. Epub 2011 Apr 15. Mol Pharm. 2011. PMID: 21438632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page